ADC Therapeutics SA — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
3
3/A
4
424B3
424B4
424B5
424B7
6-K
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
FWP
POS AM
POS EX
PRE 14A
RW
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0000902664-25-002745 | Jun 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-031894 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | FORM 4 | 0001628280-25-031890 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-059489 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | FORM 8-K | 0000950103-25-007282 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | FORM 4 | 0001628280-25-029729 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029733 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029735 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029736 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029739 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029742 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | FORM 4 | 0001628280-25-029724 | Jun 5, 2025 | Jun 3, 2025 |
| 3 | FORM 3 | 0001628280-25-029721 | Jun 5, 2025 | Jun 3, 2025 |
| 3/A | FORM 3/A | 0000950103-25-007062 | Jun 5, 2025 | Jan 2, 2024 |
| 8-K | FORM 8K | 0000950103-25-007061 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | — | 0001731122-25-000777 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001731122-25-000779 | May 19, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | — | 0001731122-25-000783 | May 19, 2025 | — |
| 8-K | 8-K | 0001628280-25-025329 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-025481 | May 14, 2025 | Mar 31, 2025 |
| 4 | FORM 4 | 0001628280-25-024021 | May 8, 2025 | May 6, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-001674 | Apr 24, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-014654 | Apr 21, 2025 | Jun 3, 2025 |
| DEFA14A | FORM DEFA14A | 0000950103-25-005077 | Apr 21, 2025 | — |
| PRE 14A | PRE 14A | 0001140361-25-012973 | Apr 9, 2025 | Jun 3, 2025 |
| 8-K | 8-K | 0001628280-25-015057 | Mar 27, 2025 | — |
| 10-K | 10-K | 0001628280-25-015131 | Mar 27, 2025 | Dec 31, 2024 |
| ARS | ARS | 0001628280-25-015137 | Mar 27, 2025 | Dec 31, 2024 |
| 4 | FORM 4 | 0001628280-25-005862 | Feb 14, 2025 | Feb 13, 2025 |
| SCHEDULE 13G | — | 0000947871-25-000166 | Feb 14, 2025 | — |
| 4 | FORM 4 | 0001628280-25-005863 | Feb 14, 2025 | Feb 13, 2025 |
| 4 | FORM 4 | 0001628280-25-005859 | Feb 14, 2025 | Feb 13, 2025 |
| 4 | FORM 4 | 0001628280-25-005860 | Feb 14, 2025 | Feb 13, 2025 |
| 4 | FORM 4 | 0001628280-25-005861 | Feb 14, 2025 | Feb 13, 2025 |
| SCHEDULE 13G | — | 0002012383-25-000418 | Feb 3, 2025 | — |
| 8-K | FORM 8-K | 0000950103-25-000411 | Jan 13, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-128575 | Dec 13, 2024 | Dec 11, 2024 |
| 4 | FORM 4 | 0001628280-24-050543 | Dec 9, 2024 | Dec 6, 2024 |
| 4 | FORM 4 | 0001628280-24-050541 | Dec 9, 2024 | Dec 6, 2024 |
| 4 | FORM 4 | 0001628280-24-050539 | Dec 9, 2024 | Dec 6, 2024 |
| 4 | FORM 4 | 0001628280-24-050540 | Dec 9, 2024 | Dec 6, 2024 |
| 4 | FORM 4 | 0001628280-24-050542 | Dec 9, 2024 | Dec 6, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-126422 | Dec 6, 2024 | Dec 4, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-119425 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-256663 | Nov 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-256678 | Nov 13, 2024 | — |
| 8-K | FORM 8-K | 0000950103-24-016242 | Nov 13, 2024 | Nov 11, 2024 |
| 8-K | 8-K | 0001628280-24-045995 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-046050 | Nov 7, 2024 | Sep 30, 2024 |
| DEF 14A | FORM DEF 14A | 0000950103-24-013848 | Sep 23, 2024 | Nov 11, 2024 |